|
No.: 09-01
Date: August 3, 2009
Foreign Corrupt Practices Act Review
Opinion Procedure Release
The Department has reviewed the FCPA Opinion request
of a U.S. company (the "Requestor") that
was submitted on June 26, 2009, along with supplemental
materials submitted on July 6, 2009, and July 31,
2009. The company is a "domestic concern"
within the meaning of the FCPA. The facts and circumstances
are as follows:
Requestor designs and manufactures a specific type
of medical device. Requestor is one of only a small
number of major global companies to design and manufacture
this type of medical device. Requestor's competitors
already operate and sell their products to the government
of a certain foreign country, but Requestor is not
well known to that country's government because its
sales in that country to date have been mainly in
the private sector.
In or about March 2009, representatives of Requestor
visited the foreign country to meet with a senior
official ("Senior Official") of a government
agency ("Government Agency"). During that
visit, the Senior Official described the foreign government's
plan to provide a specific type of medical device
for patients in need in the country and what the Senior
Official believed Requestor should do in order to
participate successfully in that program. The Senior
Official explained that the government intends to
purchase the medical devices, and then subsidize the
cost of such devices when it resells them to patients.
The Senior Official informed Requestor that all major
manufacturers would be allowed to participate in tenders
for government purchases of the medical devices, but
not all products would be endorsed by the government.
The Senior Official explained that the government
would only endorse products that it has technically
evaluated with favorable results.
Because the foreign government is not familiar with
the performance of Requestor's devices, the Senior Official
advised Requestor that in order for Requestor's devices
to be endorsed by the government, they would need to
be evaluated by the government. The Senior Official
asked Requestor to provide sample devices to government
health centers for evaluation of the technology, measured
outcomes, and feedback from the top physicians at each
center following the use of the devices in patients.
The foreign government and Requestor jointly determined
that the optimal sample size for such a study was 100
units distributed among ten experienced health centers
in the country. The number was determined based on the
size of the overall potential patient population in
the country and the government's experience with other
similar medical devices. Requestor and the foreign government
determined that providing ten medical devices each to
ten different centers would ensure valid results free
from anomalies that may result from a smaller sample
size or sampling at a smaller number of centers. Requestor
will select the centers that will participate in order
to ensure that the participating centers have the requisite
expertise, resources, and experience to successfully
participate in the evaluation.
Requestor will also provide accessories for the medical
devices free of charge, as well as standard follow-on
support. Requestor will not be responsible for the
costs of any associated medical procedures. The approximate
value of the devices and related items and services
to be provided by Requestor is $19,000 per device,
or $1.9 million for all 100 units.
The 100 recipients will be selected from a list of
candidates provided by the participating medical centers.
The centers have long lists of candidates but will
be expected to nominate candidates that best meet
certain objective criteria, which Requestor provided
with its letter of request. In addition, all candidates
will be required to present a certificate of economic
difficulty from the relevant local government authority
establishing the candidate's inability to pay. The
100 recipients will be selected from the list of candidates
by a working group of health care professionals who
are experienced in the use of this type of medical
device. Requestor's country manager in the foreign
country, a physician ("Country Manager"),
will also participate in the working group that evaluates
and selects patients who will receive the donated
devices. This will enable Requestor to ensure that
the selection criteria are met. The Country Manager
received FCPA training from Requestor in January 2008
and March 2009.
In order to ensure fairness and transparency in the
selection process, the names of the 100 recipients
will be published on the Government Agency's web site
for two weeks following the selection. In addition,
close family members (meaning immediate relatives,
as well as nieces, nephews, cousins, aunts, and uncles)
of the Government Agency's officers or employees,
working group members, or employees of the health
centers who are participating in the selection process
or in testing and evaluating the medical devices will
be ineligible to be recipients under the program unless
(a) the government-employed relatives of such recipient
hold low-level positions and are not in positions
to influence either the selection or testing process;
(b) the government-employed relatives of such recipient
clearly meet the requisite economic criteria; and
(c) the recipient is determined to be a more suitable
candidate than candidates who were not selected based
on technical criteria. Requestor agrees to provide
a report of any such determination to the Department.
In addition, the Country Manager will specifically
review the selection of any immediate family members
of any other government officials (e.g., those unaffiliated
with the medical device project or the Government
Agency) to make certain that the criteria were properly
and fairly applied and will report his determination
to Requestor's legal counsel.
The evaluation of the donated medical devices will
be based on objective criteria that are standard for
this type of medical device and that have been provided
to the Department. The results of the evaluation will
be collected by the Country Manager, who will enlist
the help of two other medical experts to review the
results and provide an overall report, as well as
individual objective results, to a senior health official
in the foreign country who will share his assessment
with the Government Agency. The Government Agency
will then evaluate the results of the evaluation and
the report by the Country Manager, along with the
senior health official's assessments, to determine
the suitability of Requestor's technology for the
medical device program. If the results of the evaluation
are favorable, Requestor's device will be identified
by the Government Agency as eligible for the subsidized
medical device program, along with the devices of
Requestor's competitors, which have already been declared
eligible. The foreign government has advised the Requestor
that none of the companies' devices will be promoted
by the foreign government above any of the other qualified
devices.
Requestor expects that more than thirty government
health centers throughout the country will receive
the evaluation results, which will in large part determine
whether those centers will purchase Requestor's products
as part of the government's medical device program.
As a result of the anticipated success of the proposed
evaluation, Requestor expects that its products will
meet all technical criteria for this program and that
its opportunities for participation in the program
will be greater as a result of the awareness among
government physicians of the performance of Requestor's
devices.
Finally, Requestor states that it has no reason to
believe that the Senior Official who suggested providing
the devices will personally benefit from the donation
of the devices and related items and services.
Based upon all of the facts and circumstances, as represented
by Requestor, the Department does not presently intend
to take any enforcement action with respect to the
proposal described in this request. This is because,
based on Requestor's representations, the proposed
provision of 100 medical devices and related items
and services fall outside the scope of the FCPA in
that the donated products will be provided to the
foreign government, as opposed to individual government
officials, for ultimate use by patient recipients
selected in accordance with specific guidelines, as
described above.
This FCPA Opinion Release has no binding application
to any party which did not join in the request, and
can be relied upon by the requestor only to the extent
that the disclosure of facts and circumstances in
its request is accurate and complete and continues
to accurately and completely reflect such facts and
circumstances. |